Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3975
-0.0225 (-5.36%)
At close: Aug 18, 2026
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $16.21 million as of August 18, 2026. Its market cap has decreased by -84.22% in one year.
Market Cap
16.21M
Enterprise Value
7.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.40
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 16.21M, a decrease of -90.19%. That is a compound annual growth rate of -35.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 16.21M | -60.93% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 23.05M |
| Oncotelic Therapeutics | 19.90M |
| ZIVO Bioscience | 17.81M |
| Finch Therapeutics Group | 16.22M |
| Synlogic | 14.27M |
| Inhibitor Therapeutics | 14.19M |
| Zeo ScientifiX | 10.97M |
| Brainstorm Cell Therapeutics | 10.92M |